AstraZeneca Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	58,739	54,073	45,811	44,351	37,417
Revenue Growth (YoY)	8.63%	18.04%	3.29%	18.53%	40.58%
Cost of Revenue	10,633	10,207	8,268	12,391	12,437
Gross Profit	48,106	43,866	37,543	31,960	24,980
Selling, General & Admin	20,512	20,532	19,755	18,955	15,680
Research & Development	14,232	13,583	10,935	9,762	9,736
Other Operating Expenses	-381	-252	-1,340	-514	-1,492
Total Operating Expenses	34,363	33,863	29,350	28,203	23,924
Operating Income	13,743	10,003	8,193	3,757	1,056
Interest Income	353	430	332	90	-21
Interest Expense	-1,694	-1,742	-1,626	-1,346	-1,300
Total Non-Operating Income (Expense)	-1,341	-1,312	-1,294	-1,256	-1,321
Pretax Income	12,402	8,691	6,899	2,501	-265
Provision for Income Taxes	2,169	1,650	938	-792	-380
Net Income	10,225	7,035	5,955	3,288	112
Minority Interest in Earnings	8	6	6	5	3
Net Income to Common	10,225	7,035	5,955	3,288	112
Net Income Growth	45.34%	18.14%	81.11%	2835.71%	-96.50%
Shares Outstanding (Basic)	3,100	3,100	3,098	3,096	2,836
Shares Outstanding (Diluted)	3,124	3,126	3,124	3,120	2,854
Shares Change (YoY)	-0.06%	0.06%	0.13%	9.32%	8.68%
EPS (Basic)	3.30	2.27	1.92	1.06	0.04
EPS (Diluted)	3.27	2.25	1.91	1.05	0.04
EPS Growth	45.33%	18.11%	80.57%	2537.50%	-96.72%
Shares Outstanding	3,102	3,101	3,100	3,100	3,099
Free Cash Flow	11,765	9,937	8,984	8,717	4,872
Free Cash Flow Growth	18.40%	10.61%	3.06%	78.92%	26.94%
Free Cash Flow Per Share	3.77	3.18	2.88	2.79	1.71
Dividends Per Share	3.200	3.100	2.900	2.900	2.870
Dividend Growth	3.23%	6.90%	-	1.04%	2.50%
Gross Margin	81.90%	81.12%	81.95%	72.06%	66.76%
Operating Margin	23.40%	18.50%	17.88%	8.47%	2.82%
Profit Margin	17.42%	13.02%	13.01%	7.42%	0.31%
FCF Margin	20.03%	18.38%	19.61%	19.65%	13.02%
EBITDA	19,476	16,691	13,580	9,237	7,586
EBITDA Margin	33.16%	30.87%	29.64%	20.83%	20.27%
EBIT	13,743	10,003	8,193	3,757	1,056
EBIT Margin	23.40%	18.50%	17.88%	8.47%	2.82%
Effective Tax Rate	17.49%	18.99%	13.60%	-31.67%	143.40%

Updated Feb 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q